IL6 and COVID-19: Interleukin-6 (IL6), a proinflammatory cytokine that enables virus to enter host cells and proliferate, is an important prognostic biomarker and a powerful predictor of COVID-19 mortality (103, 104); it is significantly increased in ICU patients, and was highly significantly correlated with COVID-19 mortality (105–107).